Ketamine has emerged as a novel therapeutic intervention for major depressive disorder, currently undergoing systematic investigation at The Cleveland Clinic. A comprehensive clinical trial, directed by Dr. Donald Malone, who serves as the head of Adult Psychiatric Services and the Director of the Psychiatric Neuromodulation Center at The Cleveland Clinic, is in progress to evaluate its efficacy in patients with severe depression.